成立于1994年香港,集醫藥中間體、藥物制劑、藥包材等生產、銷售為一體的企業,其抗菌素、膠囊系列產品行業有名
聯(lian)(lian)(lian)邦制(zhi)藥(yao)(yao)(股份(fen)(fen)代(dai)號(hao)3933.HK)1990年成立于(yu)(yu)香港,目前(qian)擁有(you)(you)(you)聯(lian)(lian)(lian)邦制(zhi)藥(yao)(yao)廠有(you)(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(香港)、珠海聯(lian)(lian)(lian)邦制(zhi)藥(yao)(yao)股份(fen)(fen)有(you)(you)(you)限(xian)公(gong)(gong)(gong)(gong)司、珠海聯(lian)(lian)(lian)邦制(zhi)藥(yao)(yao)股份(fen)(fen)有(you)(you)(you)限(xian)公(gong)(gong)(gong)(gong)司中(zhong)(zhong)山分公(gong)(gong)(gong)(gong)司、廣東開平金億膠囊有(you)(you)(you)限(xian)公(gong)(gong)(gong)(gong)司、聯(lian)(lian)(lian)邦制(zhi)藥(yao)(yao)(內(nei)蒙古)有(you)(you)(you)限(xian)公(gong)(gong)(gong)(gong)司、內(nei)蒙古聯(lian)(lian)(lian)邦動保藥(yao)(yao)品(pin)(pin)有(you)(you)(you)限(xian)公(gong)(gong)(gong)(gong)司六家生(sheng)產實體(ti),專(zhuan)業的(de)化學藥(yao)(yao)品(pin)(pin)和生(sheng)物制(zhi)品(pin)(pin)研發(fa)中(zhong)(zhong)心,產品(pin)(pin)涵蓋醫藥(yao)(yao)中(zhong)(zhong)間體(ti)、原料藥(yao)(yao)和制(zhi)劑,員(yuan)工共計約12000人(ren),是一家集(ji)研發(fa)、生(sheng)產、經(jing)營于(yu)(yu)一體(ti)的(de)綜合性制(zhi)藥(yao)(yao)集(ji)團。
聯邦(bang)制藥所(suo)有車間全部通過中國(guo)新版(ban)GMP認證,多個產品先(xian)后獲得歐盟(meng)GMP認證和美國(guo)FDA認證。憑借先(xian)進的酶(mei)法生產工(gong)藝,聯邦(bang)制藥成(cheng)為國(guo)內獲得酶(mei)法阿莫(mo)西(xi)林歐盟(meng)CEP證書的企業(ye),另有多項(xiang)科技成(cheng)果獲得國(guo)家專利。
聯(lian)邦(bang)制藥(yao)(yao)現有制劑產品(pin)11大系(xi)列60多個品(pin)種120多個品(pin)規(gui),原(yuan)料藥(yao)(yao)和(he)中間體(ti)產品(pin)共5大系(xi)列近50個品(pin)種。抗生(sheng)素產品(pin)如阿莫(mo)仙(xian)(xian)、他唑仙(xian)(xian)、安必仙(xian)(xian)等,連續暢銷多年(nian),其(qi)(qi)優良的療(liao)效和(he)品(pin)質深(shen)受用戶的信賴和(he)贊譽。2018年(nian),聯(lian)邦(bang)®阿莫(mo)仙(xian)(xian)®膠囊(0.25g)和(he)聯(lian)邦(bang)賽福欣®片(0.25g)相(xiang)繼獲得仿制藥(yao)(yao)質量和(he)療(liao)效一致性(xing)評(ping)價批件,表明其(qi)(qi)在(zai)質量和(he)療(liao)效上與原(yuan)研(yan)藥(yao)(yao)品(pin)一致,在(zai)臨床上與原(yuan)研(yan)藥(yao)(yao)品(pin)可以互相(xiang)替代。
聯(lian)邦制(zhi)(zhi)藥(yao)(yao)致力于(yu)生(sheng)(sheng)物(wu)研(yan)究十多(duo)年,并投入巨資在珠海和(he)中(zhong)山建(jian)立了大型(xing)的人(ren)胰(yi)島(dao)素及(ji)類似(si)物(wu)生(sheng)(sheng)產(chan)(chan)基地,實現(xian)了糖尿病(bing)生(sheng)(sheng)物(wu)制(zhi)(zhi)藥(yao)(yao)領域產(chan)(chan)研(yan)一體化。目前上(shang)市(shi)產(chan)(chan)品有重(zhong)組人(ren)胰(yi)島(dao)素注(zhu)(zhu)射液(ye)“優思靈(ling)USLIN®”系(xi)(xi)列(lie)產(chan)(chan)品(R、N、30R、50R)和(he)甘精(jing)胰(yi)島(dao)素注(zhu)(zhu)射液(ye)“聯(lian)邦優樂靈(ling)®USLEN®”。優思靈(ling)USLIN®系(xi)(xi)列(lie)產(chan)(chan)品采用(yong)畢赤酵母表達技術,具有純度(du)高、安全性(xing)好、價(jia)格實惠等優勢,質(zhi)量(liang)標準(zhun)均(jun)高于(yu)現(xian)行的中(zhong)國藥(yao)(yao)典、美國藥(yao)(yao)典、歐(ou)洲藥(yao)(yao)典標準(zhun)。甘精(jing)胰(yi)島(dao)素注(zhu)(zhu)射液(ye)“聯(lian)邦優樂靈(ling)®USLEN®”采用(yong)先(xian)進的純化技術和(he)生(sheng)(sheng)產(chan)(chan)設備(bei),產(chan)(chan)品質(zhi)量(liang)符合美國藥(yao)(yao)典標準(zhun)。聯(lian)邦制(zhi)(zhi)藥(yao)(yao)是國內同時擁有第(di)二代和(he)第(di)三代胰(yi)島(dao)素生(sheng)(sheng)產(chan)(chan)能力的企業。